Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Actemra Gains New Indication for Systemic Sclerosis-Associated Interstitial Lung Disease
Ruxolitinib Gets Priority Review for Chronic Graft-vs-Host Disease
Avacopan Noninferior to Prednisone for ANCA-Associated Vasculitis
Lupkynis Approved for Active Lupus Nephritis
Locally-Delivered Sitaxsentan Designated Orphan Drug for Systemic Sclerosis
FDA Extends Expiration Date of Immunoglobulin Product Cutaquig
Belimumab Approved for Lupus Nephritis
Orladeyo Now Available for Hereditary Angioedema
No Benefit With Ruxolitinib for COVID-19 Associated Cytokine Storm
Antifibrotic Therapy Gets Orphan Drug Status for Systemic Sclerosis
New Study Supports Voclosporin Use in Lupus Nephritis Cases
FDA: More Data on Remestemcel-L for Graft Versus Host Disease Needed
FDA to Review Avacopan for ANCA-Associated Vasculitis
Newly Diagnosed Lupus Erythematosus Could Potentially Be Drug Induced
Inolimomab BLA Submitted for Graft Versus Host Disease
Voclosporin Granted Priority Review for Lupus Nephritis
Avacopan NDA Submitted for ANCA-Associated Vasculitis
Trial Investigating Ustekinumab for Systemic Lupus Erythematosus Discontinued
